贝达药业(300558.SZ)捐赠300万元用于新冠病毒肺炎疫情防控
格隆汇2月17日丨贝达药业(300558.SZ)公布,自新型冠状病毒肺炎疫情爆发以来,严峻的疫情牵动着全国人民的心。公司高度重视,密切关注新型冠状病毒疫情的进展,及时布置防控措施,全力以赴保障职工群众的生命健康安全。疫情阻击战打响后,贝达人牢记使命责任、创新工作方法,在确保自身安全防护的情况下,充分发挥公司力量履行社会责任,多为患者、多为医生着想,努力为他们提供支持和服务,全力保障患者在疫情期间也能用得上救命药。为进一步履行上市公司社会责任,公司决定以自有资金向浙江大学教育基金会医学院附属第一医院新型冠状病毒肺炎疾病专项基金、医学院附属第二医院新型冠状病毒肺炎疾病专项基金和医学院附属邵逸夫医院新型冠状病毒肺炎疾病专项基金各捐赠人民币100万元(合计金额300万元)用于支持三家医院援助武汉医疗队,为打赢新冠病毒肺炎疫情狙击战助力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.